Toyota is expected to unveil a new vaccine for the coronavirus in early 2019.
The US automaker is making the vaccine under license from a California company called Moderna, according to the Financial Times.
Moderna is the first company to develop and market a vaccine for an H1n1 strain that can be manufactured in large quantities and delivered in large numbers to hospitals and other facilities.
Honda says it has already begun the testing of the vaccine in humans, and it is expected in the first half of 2020 to start rolling out the vaccine to other manufacturers.
The company is also working on other vaccines for the virus, such as a new strain that has a shorter incubation period and is more effective against the human H1NPV.
The announcement comes as Toyota is already under pressure to do more to combat the coronas pandemic.
Its CEO, Akio Toyoda, said earlier this week that his company will invest $1 billion to make vaccines for coronaviruses.
Toyota has also invested $1.2 billion in research and development for a vaccine that has yet to be approved for use in humans.
The company said in May that it is working on developing a vaccine to fight the pandemic and it would be releasing more information in the next few months.
Toyotas first vaccine was approved in the US in 2009.